Acumen Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Acumen Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q3 2024.
  • Acumen Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $296K, a 14700% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $296K +$294K +14700% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $325K +$296K +1021% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $353K +$286K +427% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $381K +$276K +263% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $2K -$131K -98.5% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $29K -$138K -82.6% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $67K -$134K -66.7% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $105K +$105K Dec 31, 2022 10-K 2024-03-26
Q3 2022 $133K Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $167K Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $201K Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $0 Dec 31, 2021 10-K 2023-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.